Major Pharmaceutical Company Reaches Milestone $26 billion U.S. Opioid Settlement | Drug News
[ad_1] This transaction is the second largest cash settlement in the history of the United States, second only to the 1998 tobacco transaction of US$246 billion. A group of U.S. state attorneys unveiled A landmark settlement of $26 billion Mainly with the U.S. Pharmaceutical company It is accused of contributing to the deadly national opioid […]
French court deems pharmaceutical company negligent in deadly drug case
A French court has determined that a pharmaceutical company was negligent to leave a “defective” drug on the market.
Report Says Tactic Used By Pharmaceutical Companies Keeps Drug Prices Up
A lawsuit is alleging that tactics used by a major pharmaceutical company keeps prices for certain drugs high.
Lawsuit filed against Janssen Pharmaceuticals over drug side effect
A new lawsuit has been filed against the drug maker over an alleged link between the antibiotic Levaquin and nerve damage in patients.
Florida Defective Drug Litigators Report- Rue Ziffra Law Firm – Off-Label Pharmaceuticals Are a Cash Cow
deceptive trade practices, plaintiff lawyers, pharmaceutical giants, pharmaceutical industry, law firms, drug marketing, prescription drugs, whistle blower, antidepressant drugs,
The market for pharmaceutical plastic bottles will generate new growth
description New research study ?Pharmaceutical Plastic Bottles Market Analysis 2023 by Market Trends (Drivers, Restraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook? Added to Coherent Market Insight The Pharmaceutical Plastic Bottles market research report includes an analysis of the major manufacturers and geographical regions, along with advanced information on the key challenges […]
Global market for pharmaceutical anti-counterfeiting technologies
Pharmaceutical anti-counterfeiting technologies are a set of solutions and technologies used to prevent the production, distribution and sale of counterfeit medicines. This includes technologies such as RFID, holograms, barcodes and other track-and-trace solutions that help ensure the authenticity and safety of medicines throughout the supply chain. The global pharmaceutical anti-counterfeiting technology market is set to […]
Pharmacovigilance and Drug Safety Software Market in North America
The pharmacovigilance and drug safety software market in North America is expected to grow from US$73.4 million in 2019 to US$136.0 million in 2027; It is estimated to grow at a CAGR of 7.8% from 2020 to 2027. The report entitled “Pharmacovigilance and Drug Safety Software Market in North America 2022-2027” was recently added by […]
Future growth of pharmaceutical peptide services market
Pharma peptides are short chains of amino acids used in drug development. They are used to treat a variety of conditions, including cancer, heart disease and diabetes. Pharmaceutical peptides have the ability to target specific cells and tissues, making them a powerful tool for drug development. They are also used to make vaccines and other […]
Insight report on myocardial infarction pipeline drugs and companies
The myocardial infarction pipeline includes more than 7 key companies working continuously to develop more than 8 myocardial infarction treatment therapies, analysis of clinical trials, therapies, mechanisms of action, routes of administration and developments analyzed by DelveInsight. Overview of myocardial infarction Myocardial infarction (MI), colloquially known as a “heart attack,” is caused by reduced or […]
CENTESSA PHARMACEUTICALS 48 HOUR PERIOD ALERT: FORMER LOUISIANA
NEW ORLEANS, LA / ACCESSWIRE / November 26, 2022 / Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., are reminding investors that there is still time November 28, 2022 Lead Plaintiff motions to file in a securities class action lawsuit against Centessa Pharmaceuticals plc (NasdaqGS:CNTA) if […]
CENTESSA PHARMACEUTICALS SHAREHOLDER WARNING BY FORMER
NEW ORLEANS, Nov. 15, 2022 (GLOBE NEWSWIRE) — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Louisiana Attorney General Charles C. Foti, Jr., remind investors that they still have time November 28, 2022 Lead Plaintiff motions to file in a securities class action against Centessa Pharmaceuticals plc (NasdaqGS: CNTA) if they purchased or […]